Psychometric properties of a scale for measuring long covid in the Mexican population
Barra laterale dell'articolo
Contenuto principale dell'articolo
Abstract
Objective: This study aimed to translate, adapt, and validate the psychometric properties of the Modified Yorkshire Rehabilitation Scale (C19-YRSm) in Spanish for the Mexican population. Method: A total of 889 participants were recruited from February to November 2023. Invitations were extended through social media to Mexican men and women over 18 years old who had experienced COVID-19 symptoms at any point, to participate in this study by completing the C19-YRSm. Data collection took place from February to November 2023. Results: The C19-YRSm instrument demonstrated adequate scale characteristic properties. Item-total correlations ranged from 0.28 to 0.67 for SS and 0.45 to 0.75 for FD, with good internal reliability (Cronbach’s alpha of 0.87 for SS and 0.82 for FD). Convergent validity showed a strong positive association between SS and FD. Factor analysis supported a two-factor structure of SS and FD. Conclusions: The evidence presented in this research project, along with findings reported by other authors in different validations of the C19-YRSm, suggests it is a specific, valid, and reliable tool for assessing and monitoring Long Covid.
Dettagli dell'articolo
Sezione
Questo volume è pubblicato con la licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 4.0 Internazionale.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros copiar y redistribuir el material en cualquier medio o formato bajo los siguientes términos: —se debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante (Atribución); — no se puede hacer uso del material con propósitos comerciales (No Comercial); — si se remezcla, transforma o crea a partir del material, no podrá distribuirse el material modificado (Sin Derivadas).
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
Come citare
Riferimenti bibliografici
Jangnin, R., Ritruangroj, W., Kittisupkajorn, S., et al. (2024). Long-COVID prevalence and its association with health outcomes in the post-vaccine and antiviral-availability era. Journal of Clinical Medicine, 13(5), 1208. https://doi.org/10.3390/jcm13051208
Sivan, M., Rayner, C., & Delaney, B. (2021). Fresh evidence of the scale and scope of long COVID. BMJ, 373, n853. https://doi.org/10.1136/bmj.n853
Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022). Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. Journal of Infectious Diseases, 226(9), 1593–1607. https://doi.org/10.1093/infdis/jiac136
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology, 21(3), 133–146. https://doi.org/10.1038/s41579-022-00846-2
Klein, J., Wood, J., Jaycox, J., et al. (2022). Distinguishing features of long COVID identified through immune profiling. medRxiv. https://doi.org/10.1101/2022.08.09.22278592
Phetsouphanh, C., Darley, D. R., Wilson, D. B., et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nature Immunology, 23(2), 210–216. https://doi.org/10.1038/s41590-021-01113-x
Charfeddine, S., Amor, H. I. H., Jdidi, J., et al. (2021). Long COVID-19 syndrome: Is it related to microcirculation and endothelial dysfunction? Insights from TUN-ENDCOV study. Frontiers in Cardiovascular Medicine, 8, 745758. https://doi.org/10.3389/fcvm.2021.745758
Reiken, S., Sittenfeld, L., Dridi, H., Liu, Y., Liu, X., & Marks, A. R. (2022). Alzheimer’s-like signaling in brains of COVID-19 patients. Alzheimer’s & Dementia, 18(5), 955–965. https://doi.org/10.1002/alz.12558
Visser, D., Golla, S. S. V., Verfaillie, S. C. J., et al. (2022). Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET. medRxiv. https://doi.org/10.1101/2022.06.02.22275916
Guedj, E., Campion, J. Y., Dudouet, P., et al. (2021). 18F-FDG brain PET hypometabolism in patients with long COVID. European Journal of Nuclear Medicine and Molecular Imaging, 48(9), 2823–2833. https://doi.org/10.1007/s00259-021-05215-4
Smith, A., Greenwood, D., Horton, M., et al. (2024). Psychometric analysis of the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study. BMJ Open Respiratory Research, 11(1), e002271. https://doi.org/10.1136/bmjresp-2023-002271
Ho, F. F., Xu, S., Kwong, T. M. H., et al. (2023). Prevalence, patterns, and clinical severity of long COVID among Chinese medicine telemedicine service users: Preliminary results from a cross-sectional study. International Journal of Environmental Research and Public Health, 20(3), 1827. https://doi.org/10.3390/ijerph20031827
Straudi, S., Manfredini, F., Baroni, A., et al. (2022). Construct validity and responsiveness of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) in a cohort of Italian hospitalized COVID-19 patients. International Journal of Environmental Research and Public Health, 19(11), 6696. https://doi.org/10.3390/ijerph19116696
Partiprajak, S., Krongthaeo, S., Piaseu, N., Wongsathikun, J., & Kongsuwan, A. (2023). The Thai version of the COVID-19 Yorkshire Rehabilitation Scale: A valid instrument for the psychometric assessment of the community members in Bangkok, Thailand. BMC Public Health, 23(1), 15566. https://doi.org/10.1186/s12889-023-15566-2
Kustura, L., Bobek, D., Polji anin, A., et al. (2023). Psychometric properties and observational data for COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) for post-COVID-19 syndrome. QJM: An International Journal of Medicine, 117(1), 38–47. https://doi.org/10.1093/qjmed/hcad224
Go dziewicz, Ł., Tobis, S., Chojnicki, M., Wieczorowska-Tobis, K., & Neumann-Podczaska, A. (2024). The value of the COVID-19 Yorkshire Rehabilitation Scale in the assessment of post-COVID among residents of long-term care facilities. Healthcare, 12(3), 333. https://doi.org/10.3390/healthcare12030333
Do an, M. (2024). Validity and reliability of the Turkish version of the modified COVID-19 Yorkshire Rehabilitation Scale. Anatolian Journal of Family Medicine, 13, 13–20. https://doi.org/10.5505/ajfamed.2024.09797
Zhang, D., Chung, V. C. H., Chan, D. C. C., et al. (2023). Determinants of post-COVID-19 symptoms among adults aged 55 or above with chronic conditions in primary care: Data from a prospective cohort in Hong Kong. Frontiers in Public Health, 11, 1138147. https://doi.org/10.3389/fpubh.2023.1138147
Kabir, M. F., Yin, K. N., Jeffree, M. S., et al. (2023). Profile of long COVID symptoms needing rehabilitation: A cross-sectional household survey of 12,925 SARS-CoV-2 cases between July and December 2021 in Bangladesh. Archives of Public Health, 81(1), 11–40. https://doi.org/10.1186/s13690-023-01140-0
Tamadoni, N., Bakhtiari, A., & Nikbakht, H. A. (2024). Psychometric properties of the COVID-19 Yorkshire Rehabilitation Scale: Post-COVID-19 syndrome in Iranian elderly population. BMC Infectious Diseases, 24(1), 89–91. https://doi.org/10.1186/s12879-024-08991-0
Bucciarelli, V., Nasi, M., Bianco, F., et al. (2022). Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference. Trends in Cardiovascular Medicine, 32(1), 12–17. https://doi.org/10.1016/j.tcm.2021.09.009
Cohen, J., & Van Der Meulen Rodgers, Y. (2023). An intersectional analysis of long COVID prevalence. International Journal for Equity in Health, 22(1), 72–75. https://doi.org/10.1186/s12939-023-02072-5
García, B. A., Balado, Y. B., López, A. P., et al. (2023). Assessment of post-COVID symptoms using the C19-YRS tool in a cohort of patients from the first pandemic wave in Northwestern Spain. Telemedicine and e-Health, 29(2), 278–283. https://doi.org/10.1089/tmj.2022.0085
Zhou, F., Yu, T., Du, R., et al. (2022). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3